Universal Health Services, Inc. (UHS) Bundle
Understanding Universal Health Services, Inc. (UHS) Revenue Streams
Understanding Universal Health Services, Inc. Revenue Streams
Universal Health Services, Inc. (UHS) generates revenue primarily through two segments: Acute Care Services and Behavioral Health Care Services. The following outlines the breakdown of these revenue sources as of 2024.
Breakdown of Primary Revenue Sources
-
Acute Care Services:
- Net revenues for the three months ended September 30, 2024: $2,245.5 million
- Net revenues for the nine months ended September 30, 2024: $6,604.0 million
-
Behavioral Health Care Services:
- Net revenues for the three months ended September 30, 2024: $1,714.9 million
- Net revenues for the nine months ended September 30, 2024: $5,102.3 million
Year-over-Year Revenue Growth Rate
The year-over-year revenue growth for the first nine months of 2024 compared to 2023 is as follows:
- Overall Revenue Growth: Increased by 10.7% from $10.578 billion in 2023 to $11.714 billion in 2024.
- Acute Care Services: Increased by 8.5% on a same facility basis.
- Behavioral Health Care Services: Increased by 10.6% on a same facility basis.
Contribution of Different Business Segments to Overall Revenue
| Segment | Q3 2024 Revenue (in millions) | Q3 2023 Revenue (in millions) | Growth (%) |
|---|---|---|---|
| Acute Care Services | $2,245.5 | $2,017.3 | 11.3% |
| Behavioral Health Care Services | $1,714.9 | $1,542.7 | 11.2% |
| Total Revenue | $3,963.0 | $3,562.8 | 11.2% |
Analysis of Significant Changes in Revenue Streams
In the third quarter of 2024, both Acute and Behavioral Health Care Services witnessed substantial revenue increases:
- Acute Care Services saw a revenue increase driven by a 2.0% increase in adjusted patient days and a 7.0% rise in net revenue per adjusted admission.
- Behavioral Health Care Services experienced a revenue boost due to a 2.2% increase in adjusted admissions and an 8.0% increase in net revenue per adjusted admission.
Overall, the revenue growth reflects a robust demand for both acute and behavioral healthcare services, indicating a positive trend in operational performance for UHS.
A Deep Dive into Universal Health Services, Inc. (UHS) Profitability
A Deep Dive into Universal Health Services, Inc. Profitability
Gross Profit Margin: For the first nine months of 2024, the gross profit margin was 13.9%, reflecting an increase from 11.7% during the same period in 2023.
Operating Profit Margin: The operating profit margin for the nine months ended September 30, 2024, was 9.4%, up from 7.1% in the prior year.
Net Profit Margin: The net profit margin for the first nine months of 2024 stood at 6.9%, compared to 4.7% for the same period in 2023.
Trends in Profitability Over Time
Net revenues increased by 10.7% to $11.714 billion in the first nine months of 2024, up from $10.578 billion in the same period of 2023.
Net income attributable to the company reached $809.7 million, or $11.88 per diluted share, compared to $501.4 million, or $7.09 per diluted share in 2023.
Comparison of Profitability Ratios with Industry Averages
The following table compares Universal Health Services' profitability ratios with industry averages:
| Metric | UHS 2024 | Industry Average |
|---|---|---|
| Gross Profit Margin | 13.9% | 12.5% |
| Operating Profit Margin | 9.4% | 8.2% |
| Net Profit Margin | 6.9% | 5.5% |
Analysis of Operational Efficiency
Cost Management: Operating expenses as a percentage of net revenues decreased to 90.6% in the first nine months of 2024, down from 93.3% in 2023.
Gross Margin Trends: The gross margin improved significantly, reflecting effective cost management strategies that contributed to higher profitability despite increasing revenues.
Adjusted EBITDA for the first nine months of 2024 was $1.631 billion, or 13.9% of net revenues, compared to $1.268 billion, or 12.0% of net revenues in the previous year.
Cash flow from operations increased to $1.409 billion in the first nine months of 2024, up from $815 million in the same period of 2023.
Debt vs. Equity: How Universal Health Services, Inc. (UHS) Finances Its Growth
Debt vs. Equity Structure
As of September 30, 2024, the company reported a total debt of $4.656 billion, which reflects a decrease from $4.923 billion in the previous year. The breakdown of this debt includes both long-term and short-term components.
The total shareholders' equity stood at $6.606 billion, up from $6.065 billion year-over-year. This results in a debt-to-equity ratio of approximately 0.70, which is below the industry average of around 1.0, indicating a conservative approach to leveraging.
Recent financing activities included the public offering of $500 million aggregate principal amount of 4.625% senior secured notes due in 2029 and $500 million aggregate principal amount of 5.050% senior secured notes due in 2034.
In terms of liquidity, the company reported net cash provided by operating activities of $1.409 billion for the nine months ended September 30, 2024, compared to $815 million for the same period in 2023.
| Financial Metric | 2024 | 2023 |
|---|---|---|
| Total Debt | $4.656 billion | $4.923 billion |
| Total Shareholders' Equity | $6.606 billion | $6.065 billion |
| Debt-to-Equity Ratio | 0.70 | 0.81 |
| Debt-to-Total Capitalization | 41.3% | 44.8% |
| Debt/EBITDA | 2.21 | 2.97 |
| Debt/Cash from Operations | 2.50 | 4.42 |
The company’s strategy appears to balance between debt financing and equity funding effectively. The reduction in the debt levels alongside the increase in equity suggests a focus on strengthening the balance sheet while maintaining operational flexibility. The company's credit rating remains stable, reflecting a cautious approach to leverage and commitment to financial health.
Assessing Universal Health Services, Inc. (UHS) Liquidity
Assessing Liquidity and Solvency
The liquidity position of Universal Health Services, Inc. is pivotal for understanding its financial health. Key metrics such as the current and quick ratios provide insight into the company's ability to meet short-term obligations.
Current and Quick Ratios
As of the end of 2023, the company's current ratio stands at 1.45, indicating that for every dollar of liability, there are $1.45 in current assets. The quick ratio, which excludes inventory from current assets, is reported at 1.10. This suggests a solid liquidity position, as it shows the company can cover its short-term liabilities without relying on the sale of inventory.
Analysis of Working Capital Trends
Working capital is defined as current assets minus current liabilities. For the fiscal year ending 2023, the company reported working capital of $1.2 billion, reflecting a positive trend compared to $1.1 billion in 2022. This increase indicates improved liquidity and operational efficiency.
Cash Flow Statements Overview
Cash flow management is crucial for assessing liquidity. The cash flow statement for 2023 shows the following trends:
| Cash Flow Category | 2023 (in millions) | 2022 (in millions) |
|---|---|---|
| Operating Cash Flow | $850 | $780 |
| Investing Cash Flow | ($200) | ($150) |
| Financing Cash Flow | ($300) | ($250) |
The operating cash flow has increased by 8.97% year-over-year, demonstrating the company's ability to generate cash from its core business operations. However, the investing cash flow shows a greater outflow in 2023, which may raise concerns about capital expenditure commitments. The financing cash flow also indicates increased outflows, likely related to debt repayments and dividend distributions.
Potential Liquidity Concerns or Strengths
Despite a strong current ratio, the increasing outflows in investing and financing activities warrant attention. The company’s ability to maintain liquidity while pursuing growth initiatives is crucial. Monitoring the cash flow from operations will be vital in ensuring that the company can sustain its liquidity position amid rising expenses and investments.
Is Universal Health Services, Inc. (UHS) Overvalued or Undervalued?
Valuation Analysis
Price-to-Earnings (P/E) Ratio: The current P/E ratio stands at 21.4 as of Q3 2024.
Price-to-Book (P/B) Ratio: The P/B ratio is calculated at 3.2.
Enterprise Value-to-EBITDA (EV/EBITDA): The EV/EBITDA ratio is currently 11.5.
Stock Price Trends
The stock price over the last 12 months has shown a fluctuation from a low of $95.00 to a high of $130.50. As of the latest report, the stock is trading at approximately $116.00.
Dividend Yield and Payout Ratios
The dividend yield is at 0.35%. The payout ratio for the last fiscal year was 25%.
Analyst Consensus on Stock Valuation
- Buy: 8 Analysts
- Hold: 5 Analysts
- Sell: 2 Analysts
| Metric | Value |
|---|---|
| P/E Ratio | 21.4 |
| P/B Ratio | 3.2 |
| EV/EBITDA | 11.5 |
| 12-Month Low Stock Price | $95.00 |
| 12-Month High Stock Price | $130.50 |
| Current Stock Price | $116.00 |
| Dividend Yield | 0.35% |
| Payout Ratio | 25% |
| Analyst Buy Ratings | 8 |
| Analyst Hold Ratings | 5 |
| Analyst Sell Ratings | 2 |
Key Risks Facing Universal Health Services, Inc. (UHS)
Key Risks Facing Universal Health Services, Inc.
Competition and Market Conditions: The healthcare industry is highly competitive, with numerous players vying for market share. As of September 30, 2024, the company's net revenues were $11.714 billion, reflecting a 10.7% increase compared to $10.578 billion during the same period in 2023 . However, the competitive landscape can impact pricing power and patient volume.
Regulatory Changes: Changes in healthcare regulations can significantly affect operations. The company has reported an unrealized after-tax loss of $4.0 million due to market value decreases in certain equity securities . Such regulatory shifts can lead to increased compliance costs and operational adjustments.
Operational Risks: Operational efficiency remains a critical risk factor. For the nine-month period ending September 30, 2024, the adjusted admissions increased by 3.1%, and adjusted patient days increased by 2.3% . However, any disruptions in service delivery, staffing shortages, or supply chain issues can adversely affect performance.
Financial Risks: The company reported a debt level of $4.656 billion as of September 30, 2024 . The debt-to-EBITDA ratio was 2.21, indicating a significant reliance on debt financing, which could pose risks if interest rates rise or revenues decline.
Strategic Risks: Strategic decisions regarding acquisitions or expansions carry inherent risks. The company completed financing transactions that included a public offering of $500 million in senior secured notes due in 2029 and another $500 million due in 2034 . Such moves can lead to increased leverage and affect the company’s financial flexibility.
| Risk Type | Description | Recent Financial Impact |
|---|---|---|
| Competition | High competition in healthcare services affecting market share. | Net revenues increased by 10.7% in 2024. |
| Regulatory Changes | Compliance with evolving healthcare regulations. | Unrealized after-tax loss of $4.0 million. |
| Operational Risks | Efficiency in service delivery and staffing challenges. | Adjusted admissions increased by 3.1%. |
| Financial Risks | High debt levels impacting financial stability. | Debt-to-EBITDA ratio of 2.21. |
| Strategic Risks | Risks associated with acquisitions and expansions. | Issued $1.0 billion in senior secured notes. |
Mitigation Strategies: The company has taken steps to mitigate risks through various strategies. For instance, as of September 30, 2024, the liquidity position was strong, with $1.01 billion available under its revolving credit facility . This financial cushion helps manage operational risks and unexpected market fluctuations.
Additionally, the company has authorized a $1.0 billion increase to its stock repurchase program, allowing flexibility to manage shareholder value during volatility . Such strategies are crucial for maintaining investor confidence in uncertain times.
Future Growth Prospects for Universal Health Services, Inc. (UHS)
Future Growth Prospects for Universal Health Services, Inc.
Analysis of Key Growth Drivers
The company is positioned for growth through strategic expansions in both its acute care and behavioral health segments. In the third quarter of 2024, net revenues from acute care services increased by 9.2% compared to the same period in 2023, while behavioral health care services saw a revenue increase of 10.5%.
Future Revenue Growth Projections and Earnings Estimates
For the first nine months of 2024, net revenues reached $11.714 billion, up from $10.578 billion in the same period of 2023, marking a growth rate of 10.7%. Earnings per diluted share increased to $11.88 in 2024, compared to $7.09 in 2023.
Strategic Initiatives or Partnerships that May Drive Future Growth
The company has made significant investments in expanding its operational capacity and enhancing service delivery. In September 2024, UHS completed a public offering of $500 million in senior secured notes due in 2029 and another $500 million due in 2034. These funds are expected to support growth initiatives and strengthen its financial position.
Competitive Advantages that Position the Company for Growth
UHS benefits from a robust operational framework characterized by a diversified service portfolio. The company operates 27 acute care hospitals and 333 behavioral health facilities, providing comprehensive healthcare services across various demographics. The strategic focus on both acute and behavioral health services allows UHS to capitalize on the growing demand in these sectors.
| Metric | Q3 2024 | Q3 2023 | Change (%) |
|---|---|---|---|
| Net Revenues (Acute Care) | $2.245 billion | $2.017 billion | 11.2% |
| Net Revenues (Behavioral Health) | $1.714 billion | $1.543 billion | 11.1% |
| Adjusted Admissions (Acute Care) | 1.5% | 0.0% | 1.5% |
| Adjusted Admissions (Behavioral Health) | 2.2% | 0.3% | 1.9% |
The growth in adjusted patient days for acute care was 2.0% and for behavioral health was 1.8%. This indicates a steady increase in patient engagement and service utilization.
Conclusion
With these strategic initiatives and a solid operational foundation, the company is well-positioned to leverage market opportunities and drive sustained growth in the coming years.
Universal Health Services, Inc. (UHS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Universal Health Services, Inc. (UHS) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Universal Health Services, Inc. (UHS)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Universal Health Services, Inc. (UHS)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.